Orion Pharma, Qilu Pharma Europe agree on biosimilar for European market
Orion Pharma has announced an agreement with Qilu Pharma Europe to commercialize a pembrolizumab biosimilar in the European market.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.